Effects Of Aspirin And Folic Acid On Inflammation Markers For Colorectal Adenomas

Main Category: Colorectal Cancer
Also Included In: Pain / Anesthetics;  Nutrition / Diet
Article Date: 13 Oct 2009 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (4 votes)

Healthcare Prof:not yet rated


Unexpectedly, inflammation markers do not appear to be involved with the chemopreventative effect of aspirin on colorectal adenomas, according to a brief communication published online October 12 in the Journal of the National Cancer Institute.

Aspirin has been shown to prevent the recurrence of colorectal polyps, but it's not clear how it works. One hypothesis is that it may affect the levels of substances, such as C-reactive protein and others, that are markers of inflammation.

To study this, Gloria Y.F. Ho, Ph.D., of the department of Epidemiology & Population Health, at Albert Einstein College of Medicine in Bronx, N.Y., and colleagues examined changes in plasma levels of five inflammation markers - C-reactive protein, interleukin 6, tumor necrosis factor, soluble TNF receptor type II, and IL-1 receptor antagonist - at baseline and at year 3 of 884 subjects. The trial had three aspirin groups (including an aspirin placebo group) and two folic acid groups (including a folate placebo group).

Changes in levels of all five inflammation markers were not associated with adenoma recurrence. For those who did not receive folic acid, C-reactive protein levels in those in the 325 mg/d aspirin group changed very little, whereas it was statistically significantly increased in the placebo group. For subjects who received folic acid, the reverse association was observed.

"Our data suggest that low dose aspirin has modest effects on stabilizing [C-reactive protein], which may be abrogated by a high level of folate," the authors write. "However, such beneficial effects do not appear to confer protection against colorectal neoplasia. Inflammation markers do not mediate the previously observed effects of aspirin and folic acid on colorectal adenomas."

Source:
Steve Graff
Journal of the National Cancer Institute

Article adapted by Medical News Today from original press release.
Visit our colorectal cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Steve Graff. "Effects Of Aspirin And Folic Acid On Inflammation Markers For Colorectal Adenomas." Medical News Today. MediLexicon, Intl., 13 Oct. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/167138.php>

APA
Steve Graff. (2009, October 13). "Effects Of Aspirin And Folic Acid On Inflammation Markers For Colorectal Adenomas." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/167138.php.

Please note: If no author information is provided, the source is cited instead.


Colorectal Cancer

What Is Colorectal Cancer?

Colorectal cancer is also known as bowel cancer. The UK National Health Service says colorectal cancer is the most common cancer globally today. However, the World Health Organization says it is the second most common cancer, after lung cancer. Read more...

Most Popular Articles



Follow Our Colorectal Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Colorectal Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »